Funny how things coincide. I mentioned in my post on the BioAgenda Summit that drug prices were a big topic of discussion. One idea for bringing costs down was giving consumers more information about drugs so they can make decisions about the relative merits of drugs and their costs. Then this morning in my local paper there was an article ...

Sarah is doing a great job blogging the SXSW (whatever that means) conference she’s attending. I admire that; I’ve never been able to write coherently about what I’m listening to. So I’m reporting about 2006 BioAgenda Summit after the fact. I might subtitle the meeting: The Conference of Conundrums. One of the themes running throughout the meeting was the religious ...

Mike Mitchel and I are attending one of the most interesting conferences about life science in the country. It’s the BioAgenda Summit near Palm Springs. It covers a wide range of issues about where life science is going–or is "taking us"–and about the industry of biotechnology. There are amazing people here. Well, to get ready for the conference we had–groan!–homework. ...

Whilst reading Stowe Boyd’s /Message I picked up on a post by Greg Olsen of Charter Street called "Going Bedouin." It’s a recurring theme in Silicon Valley that it’s desirable–at least to some minds–to stay as flexible and mobile in work style as possible. The more enterprises build structure as a result of success, the more they become encumbered. An ...